BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 28509606)

  • 1. Combined immunotherapy of breast cancer with EGF and VEGF vaccines from DNA shuffling in a mouse model.
    Jin D; Yu X; Chen B; Li Z; Ding J; Zhao X; Qi G
    Immunotherapy; 2017 Jun; 9(7):537-553. PubMed ID: 28509606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constructing Tumor Vaccines Targeting for Vascular Endothelial Growth Factor (VEGF) by DNA Shuffling.
    Bie N; Zhao X; Li Z; Qi G
    J Immunother; 2016 Sep; 39(7):260-8. PubMed ID: 27428264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy of hepatocellular carcinoma by DNA shuffling-based VEGF vaccine and doxorubicin.
    Li Z; Ding J; Zhao X; Qi G
    Immunotherapy; 2018 Aug; 10(11):951-969. PubMed ID: 30114953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model.
    Eralp Y; Wang X; Wang JP; Maughan MF; Polo JM; Lachman LB
    Breast Cancer Res; 2004; 6(4):R275-83. PubMed ID: 15217493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cripto-1 Plasmid DNA Vaccination Targets Metastasis and Cancer Stem Cells in Murine Mammary Carcinoma.
    Witt K; Ligtenberg MA; Conti L; Lanzardo S; Ruiu R; Wallmann T; Tufvesson-Stiller H; Chambers BJ; Rolny C; Lladser A; Lundqvist A; Cavallo F; Kiessling R
    Cancer Immunol Res; 2018 Nov; 6(11):1417-1425. PubMed ID: 30143536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved efficacy of DNA vaccination against breast cancer by boosting with the repeat beta-hCG C-terminal peptide carried by mycobacterial heat-shock protein HSP65.
    Yi H; Rong Y; Yankai Z; Wentao L; Hongxia Z; Jie W; Rongyue C; Taiming L; Jingjing L
    Vaccine; 2006 Mar; 24(14):2575-84. PubMed ID: 16420967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic naked DNA vaccination with the human vascular endothelial growth factor induces an anti-tumor response in C57Bl/6 mice.
    Bequet-Romero M; Ayala M; Acevedo BE; Rodríguez EG; Ocejo OL; Torrens I; Gavilondo JV
    Angiogenesis; 2007; 10(1):23-34. PubMed ID: 17273909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of therapeutic DNA vaccine potency by melatonin through inhibiting VEGF expression and induction of antitumor immunity mediated by CD8+ T cells.
    Baghban Rahimi S; Mohebbi A; Vakilzadeh G; Biglari P; Razeghi Jahromi S; Mohebi SR; Shirian S; Gorji A; Ghaemi A
    Arch Virol; 2018 Mar; 163(3):587-597. PubMed ID: 29149434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CIGB-247: a VEGF-based therapeutic vaccine that reduces experimental and spontaneous lung metastasis of C57Bl/6 and BALB/c mouse tumors.
    Bequet-Romero M; Morera Y; Ayala-Ávila M; Ancizar J; Soria Y; Blanco A; Suárez-Alba J; Gavilondo JV
    Vaccine; 2012 Feb; 30(10):1790-9. PubMed ID: 22240345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of epitope-optimized DNA vaccination and passive infusion of monoclonal antibody against HER2/neu leads to breast tumor regression in mice.
    Orlandi F; Guevara-Patiño JA; Merghoub T; Wolchok JD; Houghton AN; Gregor PD
    Vaccine; 2011 May; 29(20):3646-54. PubMed ID: 21435405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibitory effect of Adp53 and F56 on growth and metastasis of transplantation of the breast tumor in mice].
    Xiao SW; Yan B; Yang JX; Shou CC; Zhang SW
    Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Apr; 39(2):171-6. PubMed ID: 17440594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental studies of a vaccine formulation of recombinant human VEGF antigen with aluminum phosphate.
    Pérez Sánchez L; Morera Díaz Y; Bequet-Romero M; Ramses Hernández G; Rodríguez Y; Castro Velazco J; Puente Pérez P; Ayala Avila M; Gavilondo JV
    Hum Vaccin Immunother; 2015; 11(8):2030-7. PubMed ID: 25891359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of VEGF-A/VEGF-C antisense oligodeoxynucleotide on angiogenesis, lymphangiogenesis, and tumor growth of breast cancer].
    Chen JS; Zhang YJ; Hu SE; Zhang HQ
    Ai Zheng; 2007 Sep; 26(9):972-6. PubMed ID: 17927855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
    da Cunha A; Antoniazi Michelin M; Cândido Murta EF
    Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined therapeutic effect of a monoclonal anti-idiotype tumor vaccine against NeuGc-containing gangliosides with chemotherapy in a breast carcinoma model.
    Fuentes D; Avellanet J; Garcia A; Iglesias N; Gabri MR; Alonso DF; Vazquez AM; Perez R; Montero E
    Breast Cancer Res Treat; 2010 Apr; 120(2):379-89. PubMed ID: 19377876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic efficacy of a DNA vaccine targeting the endothelial tip cell antigen delta-like ligand 4 in mammary carcinoma.
    Haller BK; Bråve A; Wallgard E; Roswall P; Sunkari VG; Mattson U; Hallengärd D; Catrina SB; Hellström M; Pietras K
    Oncogene; 2010 Jul; 29(30):4276-86. PubMed ID: 20498640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antitumor effect of recombinant T7 phage vaccine expressing xenogenic vascular endothelial growth factor on Lewis lung cancer in mice].
    Li XH; Tang L; Liu D; Sun HM; Zhou CC; Tan LS; Wang LP; Zhang PD; Zhang SQ
    Ai Zheng; 2006 Oct; 25(10):1221-6. PubMed ID: 17059764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor beta inhibits angiogenesis and growth of T47D breast cancer xenografts.
    Hartman J; Lindberg K; Morani A; Inzunza J; Ström A; Gustafsson JA
    Cancer Res; 2006 Dec; 66(23):11207-13. PubMed ID: 17145865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of the chimeric plasmin-resistant VEGF165/VEGF183 (132-158) protein in murine breast cancer induces distinct vascular patterning adjacent to tumors and retarded tumor growth.
    Zhang HY; Fan BL; Wu XS; Mu LM; Wang WF; Zhu WL
    Mol Med Rep; 2015 Feb; 11(2):1483-9. PubMed ID: 25373557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune responses of breast cancer patients to mutated epidermal growth factor receptor (EGF-RvIII, Delta EGF-R, and de2-7 EGF-R).
    Purev E; Cai D; Miller E; Swoboda R; Mayer T; Klein-Szanto A; Marincola FM; Mick R; Otvos L; Wunner W; Birebent B; Somasundaram R; Wikstrand CJ; Bigner D; DeMichele A; Acs G; Berlin JA; Herlyn D
    J Immunol; 2004 Nov; 173(10):6472-80. PubMed ID: 15528389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.